Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Preferred Stock Liabilities (2024 - 2025)

Kestra Medical Technologies (KMTS) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $280.5 million as the latest value for Q1 2025.

  • On a quarterly basis, Preferred Stock Liabilities changed N/A to $280.5 million in Q1 2025 year-over-year; TTM through Jan 2025 was $280.5 million, a N/A change, with the full-year FY2024 number at $177.1 million, changed N/A from a year prior.
  • Preferred Stock Liabilities was $280.5 million for Q1 2025 at Kestra Medical Technologies, up from $177.1 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $280.5 million in Q1 2025 to a low of $177.1 million in Q2 2024.